Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 71 (1) , 35-44
Abstract
No abstract availableKeywords
Funding Information
- Gilead Sciences
- Korean National Health Clinical Research
- Ministry of Health and Welfare (HC15C3380)
- Korean Health Technology R&D Project
- Ministry of Health and Welfare (HI17C1862)
- National Research Foundation of Korea (2017R1A2B4011233)
- Technology Innovation Program (10079271)
- Ministry of Trade, Industry and Energy
This publication has 29 references indexed in Scilit:
- Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikelyJournal of Hepatology, 2013
- Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis BGut, 2010
- Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide AnaloguesHepatology, 2010
- Hepatitis B Virus Resistance to Nucleos(t)ide AnaloguesGastroenterology, 2009
- Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis BNew England Journal of Medicine, 2008
- Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failureJournal of Hepatology, 2008
- Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis BNew England Journal of Medicine, 2006
- A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis BNew England Journal of Medicine, 2006
- Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral LoadGastroenterology, 2006
- Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver DiseaseNew England Journal of Medicine, 2004